We recently published a list of Top 10 Penny Stocks That Will Skyrocket. In this article, we are going to take a look at ...

ImmunityBio, Inc.’s IBRX share price has surged by 20.86%, which has investors questioning if this is right time to sell.

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, invites current and prospective investors to its Investor ...

ImmunityBio Inc.'s $10.5 million agreement to settle an investor class action alleging misrepresentations about a cancer drug ...

CULVER CITY, Calif., March 26, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, invites current and prospective investors to its Investor Day program to be held on Tuesday ...

ImmunityBio, Inc. (NASDAQ: IBRX) Johnson Fistel, PLLP is investigating claims on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) against certain of its officers and directors. If you are a current ...

Explore ImmunityBio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IBRX. ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug HC ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, invites current and prospective investors to its Investor Day program to be held on Tuesday, April 15, 2025, at 10:00 am PDT.

CULVER CITY, Calif., February 19, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access ...